Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 23, 2010 10:01 ET | Source: Penwest Pharmaceuticals Co.

Penwest Fourth Quarter and Year End 2009 Financial Results Conference Call

PATTERSON, N.Y., Feb. 23, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Thursday, March 4, at 11:00 a.m. EST to review its financial results for...
February 09, 2010 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Initiates Second Phase IIa Clinical Trial for A0001

PATTERSON, N.Y., Feb. 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G...
January 25, 2010 09:17 ET | Source: Penwest Pharmaceuticals Co.

Penwest Enters Into Fourth Research and Development Agreement With Otsuka Pharmaceutical

PATTERSON, N.Y., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed its fourth research and development agreement with Otsuka Pharmaceutical...
January 11, 2010 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Announces Initiation of Phase IIa Clinical Trial of A0001 in Patients With Friedreich's Ataxia

PATTERSON, N.Y., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it initiated a Phase IIa clinical trial for A0001 in December and that the screening...
November 05, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Reports Third Quarter 2009 Financial Results

DANBURY, Conn., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the third quarter of 2009. Compared with the third quarter of 2008,...
October 30, 2009 13:46 ET | Source: Penwest Pharmaceuticals Co.

Penwest Third Quarter 2009 Financial Results Conference Call

DANBURY, Conn., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Thursday, November 5, at 11:00 a.m. ET to review its financial results for...
October 28, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical

DANBURY, Conn., Oct. 28, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that its formulation of a product of Otsuka Pharmaceutical Co., Ltd. that Penwest had...
October 08, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Named One of Connecticut's Fastest Growing Technology Companies

DANBURY, Conn., Oct. 8, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has been named an award winner in the Life Sciences category on the UHY LLP Tech Top...
September 03, 2009 09:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest to Present At Thomas Weisel Partners 2009 Healthcare Conference

DANBURY, Conn., Sept. 3, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...
August 07, 2009 08:00 ET | Source: Penwest Pharmaceuticals Co.

Penwest Reports Second Quarter 2009 Financial Results

DANBURY, Conn., Aug. 7, 2009 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today reported its financial results for the second quarter of 2009. Compared with the second quarter of...